NFKB1 and Miyoshi myopathy: Finally, MM-associated mutations in the non-canonical pathway seem to exacerbate the drug-resistance of malignant cells by altering the composition, and the dynamical control of the canonical NF-κB activity induced by microenvironmental cues, such as TNF.